PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: April 2009
The Regulation Wars
Last Friday, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) issued 14 untitled letters to pharma companies as a result of online advertisements that appeared as sponsored links on search engine results pages. There were already plenty of guidelines on marketing to consumers being enforced by PhRMA, but now comes a crackdown on Internet [...]
Gilead Tops the BusinessWeek 50
The best-performing company of them all? Well, according to BusinessWeek, it’s a biopharmaceutical company, Gilead Sciences, which placed first in the annual BusinessWeek 50. The company posted some impressive numbers: a 48.6 percent pretax profit as a percentage of average invested capital (taken as an average of the last three years), 38.2 average annual sales [...]
Wyeth v. Levine: Disrupting the labeling process
The recent and highly publicized Supreme Court decision in Wyeth v Levine brings into sharp focus an aggressive expansion of risk for pharmaceutical companies. Specifically, the ruling sets a precedent that approval of drug labels by the FDA does not protect against lawsuits in individual states.
While FDA compliance has never been defined as comprehensive shelter [...]
Posted in Legal, Regulatory Leave a comment
Industry Update • 4/3/2009